等待開盤 09-20 09:30:00 美东时间
0.000
0.00%
Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that the Pricing, Data Analysis, and
09-16 20:30
1H24 results were in line with BOCIe, with product sales up 22% YoY to RMB971m,...
08-30 15:11
核心观点 和黄医药公布2024 年中期业绩,肿瘤及免疫业务综合收入持续增长,2024 年上半年达到1.687 亿美元,同比增长59%。呋喹替尼自23 年11 月...
08-09 18:37
- IMM-1-104 Fast Track designation now granted for the treatment of both first and second-line pancreatic ductal adenocarcinoma (PDAC); provides potential to accelerate IMM-1-104's path to U.S. FDA submission for PDAC
08-01 04:59
RMC-6236是一款口服、可靶向突变和野生型RAS在GTP结合(具活性,ON)状态下的选择性抑制剂。
07-16 10:58
和黄医药(00013)早盘曾涨超9%,截至发稿,股价上涨6.49%,现报29.55港元,成交额1.33亿港元。 交银国际指出,索凡替尼联合PD-1一线治疗胰腺癌...
07-12 11:34
和黄医药(00013)涨超4%,截至发稿,涨4.26%,报28.15港元,成交额8556.34万港元。 智通财经APP获悉,和黄医药(00013)涨超4...
07-11 11:27
REDWOOD CITY, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- Revolution ...
07-09 04:05